CONTEXT:  Commercial opinion piece by a RWD provider IMPACT:  Low READ TIME:  1 min Quality Level Mean [1 – 10]:  6 1. “Viraj Narayanan, vice president of life sciences with COTA Inc. discussed with Outsourcing-Pharma how the company’s use of real-world data and other complex, advanced analytical tools help its team of researchers in their patient-centric approach to drug discovery.”  2. “VN: Founded by oncologists, COTA is committed to creating a precise, patient-first approach to cancer care through the use of real-world data (RWD).”  3. “VN: The key issues sponsors should keep in mind when introducing RWD to their work include addressing challenges with the data itself and the process of establishing an overarching strategy for using RWD and RWE.”  4. “Organizations that are leading in the adoption RWE seem to have strong visionary leadership, good buy-in across cross functional stakeholders, and an integrated team that can interface between the clinical trial stakeholders and COTA, translating medical requirements into data requirements.”  5. “VN: COTA’s real-world data is being utilized by leading regulatory bodies and organizations on the forefront of cancer care and innovation.”  Source URL: https://www.outsourcing-pharma.com/Article/2021/03/22/Cancer-research-benefits-from-harnessing-real-world-data